We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Navigo Proteins

News List

Navigo Proteins Appoints Chris-Carol Bremer as Chief Development Officer B3Cnewswire
February 07, 2022
Navigo Proteins, a premier protein engineering company developing novel scaffold protein-based affinity ligands called Affilin® molecules from its Precision Targeting Toolbox...
ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors B3Cnewswire
December 03, 2021
ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company and Navigo Proteins GmbH, a premier protein engineering company developing optimized scaffold protein-based affinity ligands...
Navigo Proteins and MDimune Enter into a Research Collaboration on Affilin®-Mediated Targeting of Extracellular Vesicles americanpharmaceuticalreview
May 12, 2021
Navigo Proteins announced a technology collaboration to achieve tissue-targeting of extracellular vesicles (EVs).